InvestorsHub Logo

ku

11/24/15 8:13 PM

#243639 RE: biopharm #243529

Bio, sorry for the late response. I always appreciate your research and your upbeat approach. All I am saying is Garnick is a PPHM consultant that is getting a lot of money from us. He got us the fast track and has told us that I get approval for you in 2017. I don't recall him ever talking about 13 breast cancer responders considering that he said that the phase II lung caner data is the best he has ever seen. Keeping that in mind, wouldn't you be interested to show the follow-up data from those 13 patients to FDA for may be a BTD. He is a great consultant that is doing his job which could very well be helping to get FDA approval for a lot of immuno-oncology drugs that are getting approved these days. No disrespect to him and all IMO